###begin article-title 0
The Vitamin D Receptor Is a Wnt Effector that Controls Hair Follicle Differentiation and Specifies Tumor Type in Adult Epidermis
###end article-title 0
###begin p 1
Conceived and designed the experiments: HP. Performed the experiments: HP. Analyzed the data: FA HP. Contributed reagents/materials/analysis tools: GC HT. Wrote the paper: FW HP.
###end p 1
###begin p 2
###xml 464 469 <span type="species:ncbi:9606">Human</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
We have investigated how Wnt and vitamin D receptor signals regulate epidermal differentiation. Many epidermal genes induced by beta-catenin, including the stem cell marker keratin 15, contain vitamin D response elements (VDREs) and several are induced independently of TCF/Lef. The VDR is required for beta-catenin induced hair follicle formation in adult epidermis, and the vitamin D analog EB1089 synergises with beta-catenin to stimulate hair differentiation. Human trichofolliculomas (hair follicle tumours) are characterized by high nuclear beta-catenin and VDR, whereas infiltrative basal cell carcinomas (BCCs) have high beta-catenin and low VDR levels. In mice, EB1089 prevents beta-catenin induced trichofolliculomas, while in the absence of VDR beta-catenin induces tumours resembling BCCs. We conclude that VDR is a TCF/Lef-independent transcriptional effector of the Wnt pathway and that vitamin D analogues have therapeutic potential in tumors with inappropriate activation of Wnt signalling.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Owens1">[1]</xref>
###xml 217 220 217 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Blanpain1">[2]</xref>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Andl1">[3]</xref>
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Lowry1">[4]</xref>
###xml 322 325 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 637 640 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 642 645 629 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
###xml 966 969 944 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
###xml 971 974 949 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Gat1">[7]</xref>
###xml 976 979 954 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Chan1">[8]</xref>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 906 911 <span type="species:ncbi:9606">human</span>
Adult mammalian epidermis is maintained by stem cells that self-renew and produce progeny that differentiate along the lineages of the hair follicle (HF), sebaceous gland (SG) and interfollicular epidermis (IFE) [1], [2]. The canonical Wnt pathway controls both epidermal stem cell renewal and lineage selection [3], [4], [5]. By constructing mice with a 4-hydroxy-Tamoxifen (4OHT) inducible form of stabilized beta-catenin under the control of the keratin 14 promoter (K14DeltaNbeta-cateninER transgenics) it is possible to control the timing, location and extent of beta-catenin activation in adult epidermal stem and progenitor cells [5], [6]. Activation of beta-catenin induces growth (anagen) of existing HFs and induces ectopic follicles that arise from pre-existing follicles, SGs and IFE. On prolonged activation of beta-catenin, hair follicle tumours are induced, consistent with the finding that human pilomatricomas have activating beta-catenin mutations [6], [7], [8].
###end p 4
###begin p 5
###xml 98 101 95 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Lowry1">[4]</xref>
###xml 103 106 100 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-DasGupta1">[9]</xref>
###xml 202 206 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Palmer1">[10]</xref>
###xml 208 212 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Shah1">[11]</xref>
###xml 287 291 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Huelsken1">[12]</xref>
###xml 293 297 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Bikle1">[13]</xref>
###xml 451 455 442 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Hughes1">[14]</xref>
###xml 641 645 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Sakai1">[15]</xref>
###xml 727 731 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Cianferotti1">[16]</xref>
###xml 336 342 <span type="species:ncbi:9606">humans</span>
###xml 466 470 <span type="species:ncbi:10090">mice</span>
beta-catenin interactions with Lef1 and Tcf3 in the epidermis have been extensively characterised [4], [9]. However, in addition, beta-catenin is known to bind and activate the vitamin D receptor (VDR) [10], [11]. The VDR, like beta-catenin, is essential for adult epidermal homeostasis [12], [13]. Natural mutations in the VDR gene in humans result in familial 1,25-dihydroxyvitamin D-resistant rickets (HVDRR), which can be associated with alopecia [14]. VDR null mice develop rickets and fail to undergo the first postnatal hair growth phase (anagen), resulting in alopecia and conversion of follicles into cysts with IFE differentiation [15], which is highly reminiscent of the effects of impaired epidermal Wnt signalling [16].
###end p 5
###begin p 6
###xml 249 253 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Palmer1">[10]</xref>
###xml 441 445 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Shah1">[11]</xref>
###xml 447 451 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Skorija1">[17]</xref>
###xml 538 542 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Vegesna1">[18]</xref>
###xml 668 672 656 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Shah1">[11]</xref>
###xml 779 783 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Skorija1">[17]</xref>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 528 537 <span type="species:ncbi:10090">nude mice</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
There is evidence for both ligand dependent and independent effects of VDR. In cultured cell lines beta-catenin can bind to unligated VDR, but complex formation is enhanced by vitamin D, and beta-catenin stimulates vitamin D dependent transcription [10]. In vivo, expression of a mutant VDR that can bind beta-catenin but not vitamin D (L233S) rescues alopecia in VDR null mice, demonstrating ligand independent functions of the VDR in skin [11], [17]. However, some vitamin D analogues, including EB1089, induce hair growth in nude mice [18]. Leucine 417 of the VDR is essential for ligand dependent binding to the COOH-terminus of beta-catenin, but not to vitamin D [11]. Expression of a VDR-L417S mutant in VDR null mouse skin delays, but does not completely rescue, alopecia [17]. Taken together, these observations suggest that the ligand dependent interaction between VDR and beta-catenin contributes to hair follicle maintenance.
###end p 6
###begin p 7
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Cianferotti1">[16]</xref>
###xml 372 376 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Cianferotti1">[16]</xref>
It has recently been reported that VDR ablation leads to a gradual decrease in epidermal stem cells, consistent with postnatal hair loss [16]. Cooperative transcriptional effects of beta-catenin and Lef1 are abolished in VDR null keratinocytes, and in the absence of VDR beta-catenin activation does not induce the increase in proliferation characteristic of anagen entry [16]. These observations prompted us to examine the relative contributions of VDR and TCF/Lef to beta-catenin induced gene expression, and to explore the effects of VDR on lineage reprogramming and tumour formation in adult epidermis. We present evidence that the VDR is a TCF/Lef independent transcriptional effector of the canonical Wnt pathway that promotes HF differentiation and modulates Wnt-induced tumour formation.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
beta-catenin is a co-activator of VDR in epidermal keratinocytes
###end title 9
###begin p 10
###xml 470 479 467 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1A</xref>
###xml 582 586 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Jaaskelainen1">[19]</xref>
###xml 180 185 <span type="species:ncbi:10090">mouse</span>
Given the uncertainty regarding the role of VDR ligands in hair follicle maintenance, we began by examining the conditions under which VDR-beta-catenin complexes formed in primary mouse epidermal keratinocytes. In immunoprecipitation/Western blot assays we could not detect complex formation in the absence of Wnt3A and EB1089, or when cells were treated with a single ligand. Complex formation was only detectable when cells were stimulated with both Wnt3A and EB1089 (Figure 1A). EB1089 treatment increased the level of VDR, consistent with its ability to inhibit VDR degradation [19].
###end p 10
###begin title 11
beta-catenin is a ligand dependent co-activator of VDR.
###end title 11
###begin p 12
###xml 150 152 142 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Primary mouse keratinocytes derived from wild type, VDR null (VDR-KO) or K14DeltaNLef1 transgenic (DeltaN-Lef1) mice were treated with vehicle (-), 10-7 M EB1089 or 100 ng/ml Wnt3A, alone or in combination. (A) Wild type cells were treated for 4 h, then lysed and immunoprecipitated with VDR or HA (unrelated; UR) antibodies. Immunoprecipitates (top two panels) or total lysates (bottom four panels) were immunoblotted with the indicated antibodies. (B) Cells were transiently transfected with TOPFlash and FOPFlash. Values correspond to the ratio of TOP/FOP. (c-f) Cells were transiently transfected with 4xVDRE luciferase reporter (C-E) or K15 promoter (F) constructs. All values were corrected for the Renilla control and are represented as fold increase relative to wild type cells treated with vehicle alone. Data are means+/-S.D. of triplicate samples.
###end p 12
###begin p 13
###xml 327 338 327 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1B&#8211;D</xref>
###xml 542 551 535 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1B</xref>
###xml 654 658 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Palmer1">[10]</xref>
###xml 660 664 653 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Shah1">[11]</xref>
###xml 123 128 <span type="species:ncbi:10090">mouse</span>
We next examined how the canonical Wnt and vitamin D pathways interacted to regulate transcription. We transfected primary mouse keratinocytes with luciferase reporters of transcriptional activity: a TOPFlash reporter containing 3 TCF/Lef binding sites and a VDRE reporter consisting of 4 vitamin D response elements (4xVDRE) (Figure 1B-D). Wnt3A induced TCF/Lef1 transcriptional activity 10 fold in wild type and VDR null cells but not in cells that expressed an N-terminally truncated form of Lef1 (DeltaNLef1) unable to bind beta-catenin (Figure 1B). There was some repression of TOP-Flash activity upon EB1089 treatment alone, as reported previously [10], [11]. We hypothesise that this happens when nuclear beta-catenin levels are limiting and the VDR and Lef/TCF proteins compete for beta-catenin binding; in the presence of EB1089 more beta-catenin would bind VDR and less to Lef/TCF proteins.
###end p 13
###begin p 14
###xml 115 124 111 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1C</xref>
###xml 285 294 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1D</xref>
###xml 440 449 430 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1C</xref>
Wnt3A strongly enhanced induction of the vitamin D response construct by EB1089 in wild type and DeltaNLef1 cells (Figure 1C). Transient transfection of a stabilised beta-catenin mutant (S37A) stimulated vitamin D dependent transcription in a dose dependent manner in wild type cells (Figure 1D). As expected, there was no activation of the VDRE in VDR null cells treated with Wnt3A, beta-catenin (S37A) or EB1089, alone or in combination (Figure 1C). Transfection of wild type VDR rescued the cooperative effects of Wnt3A or S37Abeta-catenin on vitamin D dependent transcription in VDR null cells (data not shown). Taken together, the transcription reporter assays and co-immunoprecipitation experiments establish that beta-catenin binds the VDR and is a transcriptional co-activator of ligand-activated VDR in epidermal cells.
###end p 14
###begin p 15
###xml 201 204 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 325 334 319 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1E</xref>
###xml 674 683 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2A</xref>
###xml 907 916 897 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2A</xref>
###xml 1019 1030 1006 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g001">Figure 1C&#8211;E</xref>
###xml 289 294 <span type="species:ncbi:10090">mouse</span>
We next examined whether beta-catenin acted as a transcriptional co-activator of VDR on a natural promoter. Keratin 15 is expressed by stem cells in the HF bulge and in beta-catenin induced ectopic HF [5]. EB1089, but not Wnt3A, induced a luciferase reporter gene under the control of the mouse K15 promoter (proximal 5 kb) (Figure 1E). The highest induction occurred on combined treatment with EB1089 and Wnt3A. In VDR null cells the keratin 15 promoter was unresponsive. Transfection of an exogenous wild type VDR rescued the response to EB1089 and Wnt3A. We also performed real time PCR to investigate whether endogenous keratin 15 expression was modulated by vitamin D (Figure 2A). Wnt3A alone was unable to increase Krt15 mRNA levels in cultured wild type keratinocytes. However, EB1089 stimulated expression, and this effect was enhanced by Wnt3A in wild type but not in VDR null or DeltaNLef1 cells (Figure 2A). We conclude that beta-catenin acts as a transcriptional co-activator of the VDR on both artificial (Figure 1C-E) and endogenous promoters.
###end p 15
###begin title 16
Ligand activated VDR-beta-catenin complexes regulate transcription of hair follicle genes.
###end title 16
###begin p 17
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
(A-D) Cells were treated for 4 h (B-D) or 8 h (a) with (+) or without (-) Wnt3A or EB1089. (A) mRNA levels of the genes indicated were measured by real-time PCR. All values are represented as fold increase relative to wild type cells treated with vehicle alone. Data are means+/-S.D. of triplicate samples. (B-D) Wild type cells were lysed and immunoprecipitated with VDR, beta-catenin, Lef1 or unrelated antibody (HA tag; UR). Immunoprecipitated genomic DNA fragments or input controls were amplified by real-time PCR using specific primers for three regions of the mouse promoters indicated or unrelated genomic primers (UR). Data are means+/-S.D. of triplicate samples. Scaled diagrams summarize location of VDREs and TCF/Lef binding sites and the proteins bound to each region in cells treated with Wnt3A and EB1089.
###end p 17
###begin title 18
VDREs exist in the promoters of beta-catenin regulated genes
###end title 18
###begin p 19
###xml 65 72 62 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 275 278 265 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 504 512 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s005">Table S1</xref>
###xml 514 516 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s006">S2</xref>
###xml 259 274 <span type="species:ncbi:10090">transgenic mice</span>
###xml 490 495 <span type="species:ncbi:10090">mouse</span>
To investigate the significance of beta-catenin/VDR interactions in vivo, we performed a systematic analysis of the promoter regions of genes previously reported to be upregulated by 4-hydroxy-Tamoxifen (4OHT) treatment of the skin of K14DeltaNbeta-cateninER transgenic mice [5]. TCF/Lef and/or VDR binding sites were significantly enriched in 91 of the 103 genes upregulated more than 3 fold at 7 days of 4OHT treatment when compared with the same number of random promoter regions in the mouse genome (Table S1, S2). Of the 91 genes only two (p, Bdh) lacked VDREs. Two thirds (61/91) had multiple VDRE and TCF/Lef sites. 15/91 had multiple VDREs and a single TCF/Lef site. Strikingly, 13 genes contained VDREs but no TCF/Lef consensus binding sites, supporting the concept that nuclear beta-catenin can activate vitamin D/VDR target genes in the absence of TCF/Lef.
###end p 19
###begin p 20
###xml 47 55 44 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s005">Table S1</xref>
###xml 124 133 121 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s001">Figure S1</xref>
###xml 430 439 423 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2A</xref>
###xml 789 798 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2A</xref>
###xml 196 201 <span type="species:ncbi:10090">mouse</span>
Many of the genes upregulated by beta-catenin (Table S1) encode proteins that are specifically expressed in hair follicles (Figure S1). Using real time PCR to examine their expression in cultured mouse keratinocytes we could distinguish two categories of genes. One group, represented by PADI3, Gli1 and Tubb3, was induced by EB1089 alone or in combination with Wnt3A, in wild type and DeltaNLef1 cells but not in VDR null cells (Figure 2A). We conclude that these genes are VDR dependent, TCF/Lef independent Wnt targets. The second group, comprising S1003A, Dlx3, PADI1 and Krt31, were also maximally induced in wild type keratinocytes by combined treatment with EB1089 and Wnt3A, but differed from the other category in being unresponsive in both VDR null and DeltaNLef1 keratinocytes (Figure 2A). Thus these genes, like Krt15, were VDR dependent, TCF/Lef dependent Wnt targets.
###end p 20
###begin p 21
###xml 137 148 137 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2B&#8211;D</xref>
###xml 344 352 344 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s007">Table S3</xref>
###xml 745 754 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2C</xref>
###xml 1067 1076 1058 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2D</xref>
In order to characterise the transcription factor complexes binding to the promoters of these genes, we performed ChIP on three of them (Figure 2B-D). We designed primers to amplify three regions in each promoter analysed, corresponding to one region with both VDREs and TCF/Lef sites, one region with VDREs alone, and one region with neither (Table S3). We used Q-PCR to determine the abundance of each region in the ChIP relative to a control, unrelated genomic region (UR). In the keratin 15 promoter beta-catenin was present both in the region that contained exclusively VDREs (region 3) and in the site containing clustered VDREs and TCF/Lef sites (region 1), but only highly enriched when cells were stimulated with both EB1089 and Wnt3A (Figure 2C). Lef1 accumulated in region 1 only; VDR was most abundant in region 1 but was also detectable in region 3. In the S1003A promoter Lef, VDR and beta-catenin accumulated in region 1, containing clustered VDREs and TCF/Lef sites, recruitment of beta-catenin being dependent on the combination of EB1089 and Wnt3A (Figure 2D). We conclude that Krt15 and S1003A depend on beta-catenin binding to ligand activated VDR and Lef1 for Wnt induction.
###end p 21
###begin p 22
###xml 102 110 102 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s005">Table S1</xref>
###xml 112 121 112 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2B</xref>
The PADI3 promoter differed from the S100A and K15 promoters because it had no TCF/Lef binding sites (Table S1; Figure 2B). Nevertheless, beta-catenin accumulated in region 3 of the promoter, which contains three VDREs, in cells treated with EB1089 and Wnt3A. In contrast, region 1, which also has putative VDREs, was not precipitated with any antibody.
###end p 22
###begin p 23
###xml 174 183 171 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s002">Figure S2</xref>
###xml 258 270 252 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2B, C</xref>
###xml 272 285 266 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s002">Figure S2A, B</xref>
###xml 321 334 315 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s002">Figure S2A, B</xref>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
As further confirmation that beta-catenin is recruited through the VDR to region 3 of the PADI3 and K15 promoters, we performed ChIP in VDR null primary mouse keratinocytes (Figure S2). Whereas beta-catenin was recruited to these regions in wild type cells (Figure 2B, C; Figure S2A, B), it was absent in VDR null cells (Figure S2A, B).
###end p 23
###begin p 24
We conclude that beta-catenin bound and enhanced ligand activated VDR in Wnt target genes, both in presence of Lef1 (K15 and S1003A) and independently of Lef1 (PADI3).
###end p 24
###begin title 25
Ligand activated VDR cooperates with nuclear beta-catenin to induce hair differentiation
###end title 25
###begin p 26
###xml 101 108 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 386 389 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 391 394 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
###xml 612 621 599 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3A</xref>
###xml 200 215 <span type="species:ncbi:10090">transgenic mice</span>
###xml 374 379 <span type="species:ncbi:10090">mouse</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
To examine whether beta-catenin and the VDR also cooperated to promote hair follicle differentiation in vivo in adult epidermis, we tested the effect of EB1089 on 4OHT treated K14DeltaNbeta-cateninER transgenic mice from two founder lines, D2 and D4. Activation of beta-catenin stimulates proliferation and anagen entry in both high (D4) and low (D2) transgenic copy number mouse lines [5], [6]. Proliferation is stimulated to a greater extent in the D4 line, whereas ectopic HF morphogenesis is more advanced in the D2 line. The doses of EB1089 and 4OHT used did not induce epidermal changes in wild type mice (Figure 3A).
###end p 26
###begin title 27
###xml 112 127 <span type="species:ncbi:10090">transgenic mice</span>
EB1089 stimulates differentiation of ectopic hair follicles formation in the D4 line of K14DeltaNbeta-cateninER transgenic mice.
###end title 27
###begin p 28
###xml 612 615 609 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 85 88 <span type="species:ncbi:9685">cat</span>
Epidermal whole mounts (A-D) or sections (E-X) of wild type (WT) or transgenic (beta-cat-D4) tail skin treated with 4OHT and/or EB1089. (A-D) Immunolabelling for keratin 17 (green) with Hoechst (blue) and phalloidin-TRITC (red) counterstaining. Arrows indicate ectopic hair follicles in the IFE (B, C) or SG (D). Inserts in (B, C) show higher magnification views of ectopic follicles. (E-X) Immunolabelling with the antibodies shown (green) in combination with Hoechst (blue; E-X), phalloidin-TRICT (red; E, F) or anti-keratin 14 (red; g-v). (C) Dashed square indicates an epidermal unit as previously described [5]. (F) Arrow indicates keratin 15 expression in ORS of ectopic HF. Insert shows base of an ectopic follicle. (K) Cells expressing K31 are indicated by an arrow and shown at higher magnification in insert. Asterisks indicate base of ectopic HFs encircling dermal papilla (F, S, N, X). Scale bars: 100 microm (A-D), 50 microm (E-X).
###end p 28
###begin p 29
###xml 149 158 149 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3A</xref>
###xml 195 204 195 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3B</xref>
###xml 324 333 324 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3B</xref>
###xml 488 497 488 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3C</xref>
###xml 620 629 620 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3C</xref>
###xml 967 976 967 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3D</xref>
###xml 1071 1074 1071 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 1076 1085 1076 1085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3C</xref>
###xml 8 23 <span type="species:ncbi:10090">transgenic mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
When D4 transgenic mice were treated with 4OHT for 14 days, existing HFs enlarged and entered anagen and K17, which is normally confined to the ORS (Figure 3A), was expressed in the IFE and SGs (Figure 3B). Small K17 positive outgrowths appeared in the interfollicular epidermis, representing rudimentary ectopic follicles (Figure 3B and insert). When mice were treated with 4OHT and EB1089, enlargement and anagen entry of existing follicles was delayed and SG morphology was preserved (Figure 3C). The K17 positive outgrowths in the IFE were longer and resembled HFs more closely than in mice treated with 4OHT alone (Figure 3C and insert). This conclusion was based on analysis of tail skin from 16 mice treated with 4OHT alone and 16 mice treated with 4OHT+EB1089. When treatment of D4 mice with 4OHT and EB1089 was extended to 21 days, most pre-existing follicles entered normal anagen, and the major site of ectopic follicle formation switched from IFE to SGs (Figure 3D). We quantified the number of ectopic follicles in the IFE of each of 50 tail epidermal units [5] (Figure 3C). There was no significant difference in the number of ectopic follicles induced by 4OHT alone or in combination with EB1089.
###end p 29
###begin p 30
###xml 117 125 114 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2</xref>
###xml 127 135 124 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s005">Table S1</xref>
###xml 137 146 134 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s001">Figure S1</xref>
###xml 513 525 507 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3E, F</xref>
###xml 535 547 529 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3G, H</xref>
###xml 558 570 552 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3I, J</xref>
###xml 578 590 572 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3M, N</xref>
###xml 598 610 592 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3O, P</xref>
###xml 618 630 612 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3Q, R</xref>
###xml 643 655 637 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3S, T</xref>
###xml 792 804 786 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3K, L</xref>
###xml 813 825 807 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3U, V</xref>
###xml 865 877 859 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3W, X</xref>
###xml 1113 1122 1107 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s001">Figure S1</xref>
###xml 1306 1319 1300 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3E, F</xref>
###xml 1321 1339 1315 1333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 3F, L, N, X</xref>
###xml 1407 1417 1401 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s001">Figure S1C</xref>
###xml 1497 1510 1491 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3A, B</xref>
###xml 1573 1586 1564 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3C, D</xref>
Many of the genes identified as transcriptional targets of beta-catenin/VDR complexes encode hair follicle proteins (Figure 2; Table S1; Figure S1), leading us to predict that ectopic follicles induced in the presence of EB1089 would be more highly differentiated than those induced by beta-catenin activation alone. In support of this prediction, several proteins that were undetectable in ectopic follicles induced by 4OHT alone were strongly induced by the combination of EB1089 and 4OHT.. These included K15 (Figure 3E, F), PADI3 (Figure 3G, H), S1003A (Figure 3I, J), K35 (Figure 3M, N), K71 (Figure 3O, P), K34 (Figure 3Q, R), and Gli1 (Figure 3S, T). In addition, combined EB1089 and 4OHT treatment resulted in an increased proportion of cells in ectopic follicles that expressed K31 (Figure 3K, L), Dlx3 (Figure 3U, V) and CCAAT displacement protein (CDP) (Figure 3W, X), than treatment with 4OHT alone. Cells expressing each of the induced proteins were correctly positioned in the ectopic follicles according to whether the proteins are markers of the HF outer root sheath, inner root sheath or cortex (Figure S1). In addition, dermal papilla formation, visualised as alkaline phosphatase positive mesenchymal cells encircled by a 'cup' of keratinocytes, was stimulated by treatment with EB1089 (Figure S3E, F; Figure 3F, L, N, X). The VDR was expressed at the base of wild type anagen follicles (Figure S1C) and in ectopic follicles induced by 4OHT alone or in combination with EB1089 (Figure S3A, B), expression being more widespread than nuclear beta-catenin (Figure S3C, D).
###end p 30
###begin p 31
###xml 180 192 180 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3G&#8211;I</xref>
###xml 297 310 297 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3J, K</xref>
###xml 500 503 500 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 505 518 505 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3J, K</xref>
The effects of EB1089 were not accompanied by significant changes in proliferation in either the D2 or the D4 line, whether visualised by Ki67 labelling of epidermal whole mounts (Figure S3G-I) or by flow cytometric determination of the proportion of epidermal cells in S, G2+M of the cell cycle (Figure S3J, K). Thus EB1089 differs from cyclopamine treatment, which has previously been shown to improve ectopic HF morphogenesis in the D4 transgenic line by inhibiting Hedgehog-induced proliferation [5] (Figure S3J, K). We conclude that EB1089 promotes beta-catenin induced hair follicle differentiation without affecting proliferation, and that the effect is due to induction of a set of beta-catenin/VDR target genes that characterise the HF lineages.
###end p 31
###begin title 32
VDR is essential for beta-catenin induction of adult hair differentiation
###end title 32
###begin p 33
###xml 232 236 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Cianferotti1">[16]</xref>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
It has previously been reported that in VDR-/- epidermis there is a gradual decrease in the size of the stem cell compartment and that this correlates with a failure of beta-catenin to induce proliferation required for anagen entry [16]. Our data suggest the alternative hypothesis that the primary role of VDR/beta-catenin interactions is to promote transcription of genes associated with differentiation of the hair follicle lineages. To investigate this, we examined the consequences of VDR ablation by crossing VDR null mice with the D2 line of K14DeltaNbeta-cateninER transgenics.
###end p 33
###begin p 34
###xml 61 70 61 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4A</xref>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Yoshizawa1">[20]</xref>
###xml 219 228 219 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4C</xref>
###xml 325 334 325 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4G</xref>
###xml 358 367 358 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4K</xref>
###xml 502 510 499 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g002">Figure 2</xref>
###xml 568 581 565 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s004">Figure S4A, B</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
VDR heterozygous mice were indistinguishable from wild type (Figure 4A). Although in some VDR-/- mice alopecia develops as early as 3 weeks after birth [20], alopecia was not yet evident in our 8 week old VDR -/- mice (Figure 4C and data not shown). Nevertheless, the HFs were thin and elongated. Although K17 was expressed (Figure 4G) K15 was undetectable (Figure 4K), providing confirmation of our finding that both beta-catenin and VDR must be activated in order for the K15 gene to be transcribed (Figure 2). The absence of VDR was confirmed by antibody staining (Figure S4A, B).
###end p 34
###begin title 35
VDR is necessary for differentiation of beta-catenin induced hair follicles.
###end title 35
###begin p 36
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were wild-type or D2 K14DeltaNbeta-cateninER transgenics, heterozygous (+/-) or homozygous (-/-) null for the VDR and had been treated with 4OHT for 21 days. (A-D) Macroscopic views of tail skin showing extent of hair growth. (E-L) Tail epidermal whole mounts immunolabelled with the antibodies indicated (green) and counterstained with Hoechst (blue) and phalloidin-TRICT (red). Arrows and dotted lines indicate ectopic HFs arising from SGs and arrowheads indicate residual HFs. Asterisks show nonspecific SG staining. (M-B') Immunostaining of tail skin sections with the antibodies indicated (green) and anti-keratin 14 (red) with Hoechst counterstain (blue). Scale bars: 100 microm.
###end p 36
###begin p 37
###xml 223 232 216 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4B</xref>
###xml 289 298 282 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4F</xref>
###xml 638 672 628 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4J, M, O, Q, S, U, W, Y, A'</xref>
###xml 1000 1040 983 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g004">Figure 4D, H, L, N, P, R, T, V, X, Z, B'</xref>
###xml 1185 1198 1168 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s004">Figure S4C, D</xref>
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 715 719 <span type="species:ncbi:10090">mice</span>
K14DeltaNbeta-cateninER mice that were heterozygous for VDR were indistinguishable from D2 mice on a wild type background: 4OHT induced existing follicles to enter anagen, resulting in lengthening of the hairs on the tail (Figure 4B), and ectopic follicles formed, primarily from the SGs (Figure 4F). In keeping with the more extensive ectopic HF morphogenesis in D2 than D4 transgenics, ectopic follicles in D2 mice that were heterozygous for the VDR contained cells expressing many transcriptional target genes of beta-catenin/VDR complexes that are HF lineage markers, including K15, PADI3, S1003A, K31, K35, K71, K34, Gli1, and Dlx3 (Figure 4J, M, O, Q, S, U, W, Y, A'). In contrast, D2 K14DeltaNbeta-cateninER mice that were null for VDR did not enter anagen. The HFs and SGs became thickened, but instead of forming ectopic follicles the enlarged cell masses lacked the expression of all the hair specific target genes analyzed, except for Dlx3 which was detectable in a small number of cells (Figure 4D, H, L, N, P, R, T, V, X, Z, B'). Further evidence that ectopic follicle formation was inhibited came from the reduction in alkaline phosphatase positive dermal papilla cells (Figure S4C, D).
###end p 37
###begin p 38
###xml 418 430 409 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s004">Figure S4E&#8211;I</xref>
###xml 715 728 689 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s004">Figure S4J, K</xref>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
The inhibition of beta-catenin induced hair follicle differentiation did not correlate with a failure of VDR -/- epidermis to proliferate in response to beta-catenin. The proportion of proliferative cells, detected by Ki67 labelling or flow cytometry, was higher in VDR null than wild type epidermis, and the increase in proliferation on beta-catenin activation was very similar in both VDR+/- and VDR-/- backgrounds (Figure S4E-I). Induction of cyclin D1, a direct Lef1/beta-catenin target gene, was not significantly altered in K14DeltaNbeta-cateninER;VDR-/- versus K14DeltaNbeta-cateninER;VDR+/- mice, suggesting that the absence of VDR did not influence the general activity of TCF/Lef dependent transcription (Figure S4J, K).
###end p 38
###begin title 39
Ligand activated VDR is essential to prevent beta-catenin induced tumorigenesis
###end title 39
###begin p 40
###xml 337 340 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
###xml 423 432 407 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g005">Figure 5A</xref>
###xml 524 533 508 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g005">Figure 5A</xref>
###xml 708 717 692 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g003">Figure 5B</xref>
###xml 815 827 799 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s003">Figure S3G&#8211;K</xref>
###xml 216 231 <span type="species:ncbi:10090">transgenic mice</span>
###xml 384 388 <span type="species:ncbi:10090">mice</span>
If VDR/beta-catenin interactions stimulate HF differentiation, then EB1089 may inhibit beta-catenin induced tumour formation. Prolonged activation of beta-catenin signalling in the D4 line of K14DeltaNbeta-cateninER transgenic mice results in the conversion of almost all of the follicles into benign tumours known as trichofolliculomas [6], and as a result the tails of 4OHT treated mice are swollen, lumpy and ulcerated (Figure 5A). Simultaneous treatment with EB1089 and 4OHT normalised the gross appearance of the tail (Figure 5A). Histological evaluation confirmed that EB1089 blocked trichofolliculoma development, inhibiting parakeratosis, stimulating IFE differentiation and restoring normal anagen (Figure 5B and data not shown). The protective effect of EB1809 was not due to inhibition of proliferation (Figure S3G-K). We conclude that EB1089 treatment inhibits the formation of HF tumours by promoting HF differentiated gene expression.
###end p 40
###begin title 41
VDR modulates beta-catenin induced skin tumours.
###end title 41
###begin p 42
###xml 1345 1347 1304 1306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3;</sub>
###xml 36 51 <span type="species:ncbi:10090">transgenic mice</span>
###xml 336 351 <span type="species:ncbi:10090">transgenic mice</span>
###xml 576 581 <span type="species:ncbi:9606">Human</span>
(A, B) K14DeltaNbeta-cateninER (D4) transgenic mice were treated with vehicle, 4OHT, EB1089 or 4OHT+EB1089 for 21 days. (A) Macroscopic appearance of tails. (B) H&E stained tail skin sections. Arrows indicate parakeratosis and increased cornified layers. (C) H&E stained tail skin sections of wild type and K14DeltaNbeta-cateninER (D4) transgenic mice that were heterozygous (+/-) or homozygous (-/-) null for VDR, following 4OHT treatment for 21 days. Arrows indicate ectopic HF formation. eHF: ectopic hair follicles; DP: dermal papilla; eDP: ectopic dermal papilla. (D, E) Human trichofolliculoma (D) and infiltrative basal cell carcinoma (E). Serial sections were stained with H&E or immunolabelled for beta-catenin (red) and VDR (green) with Hoescht counterstain (blue). Immunolabelling corresponds to boxed regions of H&E stained sections. Arrowheads show nuclear beta-catenin and VDR. Scale bars: 100 microm (B-E), 50 microm (inserts in d, e), 10 microm (Hoescht staining inserts d,e). (F) Diagram summarizing dual role of beta-catenin as a coactivator of TCF/Lef and VDR in adult epidermis. Hair follicle differentiation requires both the canonical Wnt pathway and ligand activated VDR. In the absence of VDR differentiation is impaired, favoring tumor formation. CoR: co-repressor; beta: beta-catenin; red triangle: endogenous vitamin D3; red star: vitamin D analog EB1089. eHF: ectopic hair follicles.
###end p 42
###begin p 43
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Cianferotti1">[16]</xref>
###xml 289 292 283 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Owens1">[1]</xref>
###xml 594 603 567 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g005">Figure 5C</xref>
###xml 992 996 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Jih1">[21]</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 441 445 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
###xml 1137 1141 <span type="species:ncbi:10090">mice</span>
If the primary effect of VDR loss is to deplete the stem cell compartment [16] VDR -/- mice should be protected from beta-catenin induced tumours. However, if VDR signalling promotes the HF lineages, then loss of VDR should change the type of tumour that forms in response to beta-catenin [1]. To test these hypotheses we compared wild type;VDR+/-, K14DeltaNbeta-cateninER(D2);VDR+/-, wild type;VDR-/- and K14DeltaNbeta-cateninER(D2);VDR-/- mice, treated on the tail either with vehicle (acetone) or 4OHT for 21 days. All K14DeltaNbeta-cateninER;VDR-/- mice treated with 4OHT developed tumors (Figure 5C). The tumours did not have the histological appearance of trichofolliculomas and were negative for terminal differentiation markers of all three epidermal lineages: several hair keratins (HF), involucrin (IFE) and Oil Red (SG) (data not shown). We observed invasion of basal cells from the IFE and HF ORS, the cells having with large nuclei and small cytoplasm, which are features of BCC [21]. 18/18 4OHT treated K14DeltaNbeta-cateninER(D2);VDR-/- mice developed BCC-like tumors compared with 0/18 K14DeltaNbeta-cateninER(D2);VDR+/- mice, demonstrating a high penetrance of the phenotype.
###end p 43
###begin p 44
###xml 324 332 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s008">Table S4</xref>
###xml 501 510 495 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g005">Figure 5D</xref>
###xml 639 648 630 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g005">Figure 5E</xref>
###xml 650 658 641 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s008">Table S4</xref>
###xml 101 106 <span type="species:ncbi:9606">human</span>
###xml 147 152 <span type="species:ncbi:9606">human</span>
To investigate whether or not nuclear beta-catenin and VDR expression correlated with tumour type in human skin tumours, we examined a panel of 59 human tumours, which were categorised as basal cell carcinomas or having elements of HF differentiation (trichofolliculomas (TF), trichoepithelioma (TE), or sebaceous TF (STF) (Table S4). Those tumours with HF differentiation were characterised by high expression of both nuclear VDR and nuclear beta-catenin, particularly within the aberrant follicles (Figure 5D). In contrast, all BCCs with low VDR expression and detectable nuclear beta-catenin were characterized as infiltrative tumours (Figure 5E; Table S4). We conclude that low levels of VDR correlate with infiltrative BCCs (p<0.001).
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 44 53 44 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001483-g005">Figure 5F</xref>
###xml 485 488 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 490 493 480 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
Our results are summarised schematically in Figure 5F. In the absence of active Wnt or VDR signalling adult epidermal hair follicles are in the resting (telogen) phase of the hair growth cycle. In wild type skin the combined activation of Wnt and VDR by their endogenous ligands is required for normal anagen. Elevated and sustained activation of beta-catenin in adult K14DeltaNbeta-cateninER epidermis leads to ectopic hair follicle formation and, subsequently, to trichofolliculomas [5], [6]. In the presence of EB1089 differentiation of ectopic HFs is stimulated and trichofolliculloma development is therefore blocked. Conversely, in the absence of VDR differentiation of ectopic follicles is inhibited and the tumours that develop in response to beta-catenin are undifferentiated basal cell carcinomas.
###end p 46
###begin p 47
###xml 134 138 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Cianferotti1">[16]</xref>
###xml 265 269 265 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Benitah1">[22]</xref>
###xml 586 589 583 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
It has recently been reported that the mechanism by which VDR loss leads to postnatal alopecia is via progressive stem cell depletion [16]. Stem cell depletion results in a failure of replacement of differentiated cells and, as a result, spontaneous wounds develop [22]. In contrast, as VDR -/- mice age they develop massively wrinkled skin, more consistent with expansion of the stem cell compartment (data not shown). Furthermore, we saw no evidence that VDR loss led to an impaired proliferative response to beta-catenin, in contrast to the effects of inhibiting Hedgehog signalling [5]. All our data are consistent with the conclusion that combined activation of VDR and Wnt signalling promotes formation of TCF/Lef-beta-catenin and VDR/beta-catenin complexes that together induce genes that mediate HF differentiation.
###end p 47
###begin p 48
###xml 89 93 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Mulholland1">[23]</xref>
###xml 509 513 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Olson1">[24]</xref>
###xml 733 737 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Watt1">[25]</xref>
###xml 481 486 <span type="species:ncbi:10090">mouse</span>
beta-catenin can no longer be considered as chiefly an activator of TCF/Lef target genes [23]. The interaction of beta-catenin with other cofactors, such as VDR and Prop-1, is likely to contribute to the pleiotropic effects of the Wnt pathway, which has different target genes in different tissues. One example is the specification of the hair follicle lineages by beta-catenin/VDR complexes. A second is the role of beta-catenin binding to Prop-1 in cell lineage selection during mouse pituitary development [24]. In the skin, the ability of beta-catenin to activate or inhibit other signalling pathways, such as Notch and Hedgehog, provides further levels of complexity in the regulation of stem cell renewal and lineage selection [25].
###end p 48
###begin p 49
###xml 168 172 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Palmer2">[26]</xref>
###xml 174 178 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Pena1">[27]</xref>
###xml 493 497 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Deeb1">[28]</xref>
###xml 3 8 <span type="species:ncbi:9606">human</span>
###xml 149 154 <span type="species:ncbi:9606">human</span>
In human skin tumours with detectable nuclear beta-catenin, the level of VDR correlates with differences in tumour phenotype, a similar situation to human colon cancer [26], [27]. These results suggest that alterations in VDR-beta-catenin interactions, in combination with mutations in genes such as PTCH or p53, can modulate BCC development or progression. Vitamin D analogues may well be beneficial in the treatment of tumours in which the canonical Wnt pathway is activated inappropriately [28].
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
Antibodies, reagents and cell culture
###end title 51
###begin p 52
###xml 51 54 51 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
The antibodies used have been described previously [5], except for VDR (Chemicon), beta-catenin (BD Transduction), cytokeratins 14, 31, 34, 35, 71 (Progen), Dlx3, S1003A (Abnova), cyclin D1 (Abcam) and beta-tubulin (Sigma). CDP antibody was a gift from Dr. Patrick Michl and PADI3 antibody a gift from Dr. Michel Simon. In some experiments cells or tissues were counterstained with phalloidin (Sigma) and Hoechst 33258 (Molecular Probes).
###end p 52
###begin p 53
###xml 78 82 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Niemann1">[29]</xref>
###xml 134 137 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 191 195 187 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Willert1">[30]</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Primary keratinocytes derived from wild type, VDR null and K14DeltaNLef1 mice [29] were isolated and cultured as previously described [5]. Wnt 3A protein was purified as previously described [30]. EB1089 was a gift from Leo Pharmaceuticals.
###end p 53
###begin title 54
Bioinformatics and statistics
###end title 54
###begin p 55
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s006">Table S2</xref>
###xml 269 273 266 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Rice1">[31]</xref>
###xml 371 375 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Karolchik1">[32]</xref>
###xml 355 360 <span type="species:ncbi:10090">mouse</span>
###xml 365 370 <span type="species:ncbi:9606">human</span>
TCF/Lef and VDR variant consensus motifs were defined by comparing the natural binding sites in the promoter region of several target genes (Table S2). The sites were mapped to 3 kb of promoter sequence of the beta-catenin target genes using the Emboss program fuzznuc [31] allowing for 1 mismatch. Identified motifs were filtered on conservation between mouse and human [32]. To determine over-representation of motifs within the gene list, a background was constructed by mapping consensus motifs to 3 kb of promoter sequence for all NCBI reference sequences (RefSeq). This sequence set was then randomly sampled to derive a background distribution against which the beta-catenin target gene motif numbers were tested (p-values).
###end p 55
###begin p 56
###xml 14 19 <span type="species:ncbi:9606">human</span>
In evaluating human tumour sections we calculated the probability of infiltrative tumours having low levels of VDR and detectable levels of nuclear beta-catenin and performed a contingency analysis using the ChiSquare Test (p-values).
###end p 56
###begin title 57
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Generation and experimental treatment of mice
###end title 57
###begin p 58
###xml 94 97 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 99 102 92 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
###xml 176 180 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Yoshizawa1">[20]</xref>
###xml 401 405 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Sakai1">[15]</xref>
###xml 407 411 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Yoshizawa1">[20]</xref>
###xml 413 417 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-VanCromphaut1">[33]</xref>
###xml 47 62 <span type="species:ncbi:10090">transgenic mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
The D2 and D4 lines of K14DeltaNbeta-cateninER transgenic mice have been described previously [5], [6]. VDR -/- mice were fed with a special diet to prevent rickets (Yoshizawa [20]. At the start of each experiment, mice were 6 to 8 weeks old, and therefore in the resting phase of the hair cycle. VDR-/- mice started to develop alopecia at 9 weeks of age, which later than some other VDR null strains [15], [20], [33].
###end p 58
###begin p 59
###xml 203 208 <span type="species:ncbi:10090">mouse</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 317 322 <span type="species:ncbi:10090">mouse</span>
The K14DeltaNbeta-cateninER transgene was activated by topical application of 4-hydroxytamoxifen (4OHT; Sigma) dissolved in acetone. Tail skin was treated by applying 4OHT with a paint brush (0.5 mg per mouse every second day). In some experiments, mice received topical applications of EB1089 (1.5 mg in acetone per mouse) 30 min prior 4OHT treatment. All animal experiments had the approval of the CR-UK London Research Institute ethics committee and were carried out under a British Home Office license.
###end p 59
###begin p 60
###xml 173 177 <span type="species:ncbi:10090">mice</span>
Three independent experiments comparing D4 line of K14DeltaNbeta-cateninER transgenics and transgenic negative littermates (wild type) were performed. The combined total of mice per treatment group and genotype was 16.
###end p 60
###begin p 61
###xml 81 96 <span type="species:ncbi:10090">transgenic mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
Four independent experiments examining the D2 line of K14DeltaNbeta-cateninER of transgenic mice on a VDR-/+ or VDR-/- backgrounds, were performed. A total of 18 mice per treatment group/genotype was examined.
###end p 61
###begin title 62
Immunoprecipitation, immunoblotting and luciferase assays
###end title 62
###begin p 63
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Palmer1">[10]</xref>
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Palmer1">[10]</xref>
###xml 631 634 631 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7 </sup>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 518 523 <span type="species:ncbi:10090">mouse</span>
Primary mouse keratinocytes were grown in KSFM medium (Invitrogen-Gibco) and deprived of serum overnight prior to treatment. Cell lysis, immunoprecipitation and immunoblotting were performed as described [10], except that immunoprecipitates were washed five times with 150 mM NaCl, 10% glycerol, 1% Triton-X100 and 50 mM Hepes, pH 7.4. For luciferase assays, keratinocytes were transiently transfected with Promega luciferase reporter construct pRL (Renilla luciferase control) and TOPFLASH, FOPFLASH, 4xVDRE or -5 kb mouse Krt15 promoter (firefly luciferase) using FuGene 6 (Roche) as previously described [10] and treated with 10-7 M EB1089 and/or 100 ng/ml Wnt3A. In some experiments cells were cotransfected with pSG5-VDR or pSG5 (Mock) constructs. Luciferase activity was measured using the PerkinElmer EnVisiontrade mark system.
###end p 63
###begin title 64
RNA extraction and real time PCR
###end title 64
###begin p 65
###xml 263 282 255 274 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;tttttttttttttt 3&#8242;</named-content>
###xml 586 594 566 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s009">Table S5</xref>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
Total RNA from primary mouse keratinocytes was purified using the Tri Reagent - RNA/DNA/Protein Isolation Procedure (Helena BioSciences). Retrotranscription of mRNA to cDNA was performed using 0.5 microg of total RNA from each sample, 2.5 microM oligo dT primer (5'tttttttttttttt 3'), 0.5 mM dNTP mix, 0.05 mM DTT, 4 microl of 5x First Strand Buffer (Invitrogene) and 1 microl of Retrotranscriptase (Invitrogene) in a final 20 microl reaction. All samples where analyzed by real-time PCR using SYBR Green PCR master mix (Applied Biosystems) and specific pairs of primers for each gene (Table S5).
###end p 65
###begin title 66
Chromatin immunoprecipitation assay
###end title 66
###begin p 67
###xml 26 28 26 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 668 676 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s007">Table S3</xref>
###xml 746 754 739 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s008">Table S4</xref>
###xml 1152 1160 1109 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s009">Table S5</xref>
Cells were treated with 10-7 M EB1089 and/or 100 ng/ml Wnt3A for 4 h. 106 keratinocytes were lysed and immunoprecipitated with 2.5 microg of VDR (Sigma), beta-catenin (BD Transduction), Lef1 (Upstate Biotech) or unrelated HA (Roche) antibodies. Sonication, precipitation and washes were performed using an Upstate ChIP assay kit. All the samples where analysed by real-time PCR using SYBR Green PCR master mix (Applied Biosystems) and specific pairs of primers for two regions of each promoter that contained VDRE and/or TCF/Lef binding sites, one region that does not contain any of these sites, and a completely unrelated region of the genome as a negative control (Table S3). The sequences of the binding sites for each promoter are listed in Table S4. PCR cycles were as follows: 94degreesC for 5 min; 40 cycles of (95degreesC 15 sec, 60degreesC 20 sec, 72degreesC 15 sec), 72degreesC for 5 min, and a final 19.59 min of ramping the temperature to 95degreesC in order to calculate the dissociation curve of the PCR products. Real-Time PCR was performed with the ABI 7700 Real-Time PCR system (Applied Biosystems). The primers used are indicated in Table S5. All 64 samples were run in the same 96 well plate to allow us to compare the different levels of amplification.
###end p 67
###begin p 68
Real-time PCR was repeated more than three times within every experiment and each experiment was repeated three times. To calculate the fold values we first measured the cycle number at which the increase in fluorescence (and therefore cDNA) was logarithmic. The point at which the fluorescence crossed the threshold is called the Ct. We corrected the Ct values of each sample by the Ct value obtained for the corresponding input using the same primers or using unrelated primers. The formula used is shown as follows:
###end p 68
###begin p 69
a : Ct value for PCR of immunoprecipitated samples.
###end p 69
###begin p 70
i : Ct value for PCR of imput samples (prior immunoprecipitation).
###end p 70
###begin p 71
c : Ct value for PCR using unrelated oligos for each sample.
###end p 71
###begin p 72
DctIP : Differential Ct for the immunoprecipitates. DctIP = a-i
###end p 72
###begin p 73
DctC : Differential Ct control. DctC = c-i
###end p 73
###begin p 74
DDct : Differential between DctIP and DctC. DDct = DctIP-DctC.
###end p 74
###begin p 75
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DDct</sup>
Fold = 2DDct
###end p 75
###begin title 76
Immunohistochemistry
###end title 76
###begin p 77
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Braun1">[34]</xref>
###xml 291 294 291 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-LoCelso1">[6]</xref>
###xml 296 301 <span type="species:ncbi:9606">Human</span>
Conventional fixed, paraffin-embedded sections and tail epidermal whole mounts were prepared and immunolabeled as described previously [5]. Images were obtained using a Zeiss 510 confocal microscope [34]. Alkaline phosphatase activity was measured on frozen sections as previously described [6]. Human tumor samples were obtained with ethical approval from Yamagata University Hospital.
###end p 77
###begin title 78
Flow cytometry
###end title 78
###begin p 79
To analyze cell cycle keratinocytes isolated from epidermis were fixed with 2% paraformaldehyde (PFA) at room temperature for 10 min and then permeabilized with 0.1% Triton-X100 for 10 min. Cells were washed with PBS and re-suspended in PBS with 2% FBS containing DAPI (2 mg/ml; Sigma). Pulse processing was used in order to exclude any unstained, apoptotic or clumped cells and analysis was performed using an LSRII (Becton-Dickinson). Analysis of flow cytometry data was performed using a FlowJo 6.3.3 (Treestar Inc., Ashland, Oregon).
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
Expression of beta-catenin target genes in wild type anagen follicles. (A) H&E staining. Positions of dermal papilla (DP), hair matrix (ma), outer root sheath (ORS), inner root sheath (IRS) and hair shaft (HS) are indicated. (B-L) Immunostaining with antibodies indicated (green), anti-keratin 14 (red) and Hoescht (blue) counterstain. Scale bar: 100 micrometers.
###end p 81
###begin p 82
(9.52 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 162 167 <span type="species:ncbi:10090">mouse</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
Beta-catenin is recruited to hair follicle gene promoters by binding ligand activated VDR. (A,B) Wild type (WT; white bars) and VDR null (KO; black bars) primary mouse keratinocytes were lysed and immunoprecipitated with VDR, beta-catenin or unrelated antibody (HA tag; UR). Immunoprecipitated genomic DNA fragments or input controls were amplified by real-time PCR using specific primers for region 3 of the mouse promoters indicated or unrelated genomic primers (UR). Data are means+/-S.D. of triplicate reactions. Scaled diagrams summarize location of VDREs and TCF/Lef binding sites and the proteins bound to each region in cells treated with Wnt3A and EB1089.
###end p 84
###begin p 85
(0.91 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 113 128 <span type="species:ncbi:10090">transgenic mice</span>
###xml 742 747 <span type="species:ncbi:10090">mouse</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
###xml 948 952 <span type="species:ncbi:10090">mice</span>
EB1089 promotes ectopic hair follicle differentiation without affecting proliferation in K14DeltaNbeta-cateninER transgenic mice. Epidermal sections (A-F) or whole mounts (G-H) of D4 tail skin treated with 4OHT and/or EB1089. (A-D) Double immunolabelling with keratin 14 (red) and the antibodies shown (green), with Hoechst (blue) counterstain. Asterisks indicate ectopic HFs encircling dermal papillae. Dashed lines demarcate dermal-epidermal boundary. (E, F) Alkaline phosphatase activity (blue) with fast red counterstain. Asterisk indicates dermal papilla. (G-I) Ki67 staining (green) with phalloidin-TRITC (red) counterstain. Inserts show IFE sections. Scale bars: 50 micrometers (A-F). (J, K) DNA content of keratinocytes isolated from mouse skin was used to determine proportion of cells in different phases of the cell cycle. % cells in S+G2/M phase was calculated for mice treated as indicated. Cyclop: cyclopamine. Data shown are for two mice of each founder line per treatment.
###end p 87
###begin p 88
(5.85 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
Lack of VDR impairs beta-catenin induced hair follicle differentiation but not proliferation. D2 mice were treated with 4OHT for 21 days and tail epidermis was analyzed. (A, B) Double immunostaining of tail skin sections with antibodies to keratin 14 (red) and VDR (green) with Hoechst counterstain (blue). (C, D) Alkaline phosphatase activity (blue) with Fast Red counterstain. Dashed line in (C) indicates dermal-epidermal junction. (E-H) Whole mount staining for Ki67 with Hoescht (blue) and phalloidin (red) counterstains. (I) % cells in S+G2/M was determined by flow cytometry. Data shown are for two mice of each genotype. (J, K) Immunohistochemistry for cyclin D1 (brown). Positive staining is indicated by arrows. eHF: ectopic hair follicle; eDP: ectopic dermal papilla. Scale bars: 100 micrometers.
###end p 90
###begin p 91
(5.18 MB TIF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-SilvaVargas1">[5]</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Jaaskelainen1">[19]</xref>
###xml 210 214 <span type="species:ncbi:10090">mice</span>
###xml 361 366 <span type="species:ncbi:10090">mouse</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
TCF/Lef and VDR binding sites in the promoter regions of beta-catenin target genes. The 3 kb proximal promoter region of 91 genes upregulated more than 3 fold in transgenic skin of K14DeltaNbeta-cateninER (D2) mice treated with 4OHT for 7 days [5] was analyzed. The numbers of putative TCF/Lef and VDR variant consensus motifs, filtered on conservation between mouse and human, are shown [19]. The list is organized into different groups according to the abundance of VDREs and TCF/Lef binding sites. Within each group genes are ranked according to fold upregulation on the original microarrays. Genes with multiple LEF and VDR sites are subdivided according to whether they have fewer TCF/Lef sites than VDREs, similar numbers of both types of sites or lower number of VDREs than TCF/Lef sites.
###end p 93
###begin p 94
(0.03 MB DOC)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
###xml 157 165 157 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s005">Table S1</xref>
###xml 546 554 546 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001483.s005">Table S1</xref>
###xml 556 560 556 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001483-Jaaskelainen1">[19]</xref>
Enrichment of TCF/Lef and VDR binding sites in the promoter of beta-catenin target genes. To determine over-representation of motifs within the gene list in Table S1, a background was constructed by mapping consensus motifs to 3 kb of promoter sequence for all NCBI reference sequences (RefSeq). This sequence set was then randomly sampled to derive a background distribution against which the beta-catenin target gene motif numbers were tested (p-values). The total number of TCF/Lef binding sites (303) was calculated for the 91 genes studied (Table S1) [19]. The presence of 11 different VDR binding motifs was analyzed in the same 91 genes. 5 types of VDREs were significantly enriched in the gene list (p<0.05), with 414 sites present. The presence of the other VDREs (55 sites) was not significantly increased in the gene list (p>0.05). The references listed correspond to the original reports of natural TCF/Lef and VDR binding sites, used to define the consensus motifs. The consensus motifs use a degenerate code: A = A, C = C, G = G, T = T, R = AG, Y = CT, M = AC, K = GT, W = AT, S = CG, B = CGT, D = AGT, H = ACT, V = ACG, N = ACGT.
###end p 96
###begin p 97
(0.04 MB DOC)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
VDR and Lef1 binding sites in the promoter regions of Krt15, PADI3 and S1003A genes. For each gene the actual sequence present in the mouse promoter is shown (real site), together with the corresponding consensus binding site and the regions in the ChIP analysis. Sequences are numbered in order, according to their relative proximity to the transcription start (number 1 being closest). DR: Direct Repeat. IP: inverted palindrome.
###end p 99
###begin p 100
(0.07 MB DOC)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
VDR and nuclear beta-catenin expression in human skin tumours. 59 human skin tumors were stained for VDR and beta-catenin. Expression was scored as high, medium or low. In green are highlighted all tumors with elements of hair follicle differentiation; these had high levels of both VDR and nuclear beta-catenin. In red are indicated those infiltrative BCCs that had high nuclear beta-catenin and low VDR.
###end p 102
###begin p 103
(0.08 MB DOC)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
Primers used for real time PCR
###end p 105
###begin p 106
(0.02 MB DOC)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin title 108
References
###end title 108
###begin article-title 109
Contribution of stem cells and differentiated cells to epidermal tumours.
###end article-title 109
###begin article-title 110
Epidermal stem cells of the skin.
###end article-title 110
###begin article-title 111
WNT signals are required for the initiation of hair follicle development.
###end article-title 111
###begin article-title 112
Defining the impact of beta-catenin/Tcf transactivation on epithelial stem cells.
###end article-title 112
###begin article-title 113
Beta-catenin and Hedgehog signal strength can specify number and location of hair follicles in adult epidermis without recruitment of bulge stem cells.
###end article-title 113
###begin article-title 114
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
Transient activation of beta-catenin signalling in adult mouse epidermis is sufficient to induce new hair follicles but continuous activation is required to maintain hair follicle tumours.
###end article-title 114
###begin article-title 115
###xml 55 59 <span type="species:ncbi:10090">mice</span>
De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin.
###end article-title 115
###begin article-title 116
###xml 9 14 <span type="species:ncbi:9606">human</span>
A common human skin tumour is caused by activating mutations in beta-catenin.
###end article-title 116
###begin article-title 117
Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation.
###end article-title 117
###begin article-title 118
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
###end article-title 118
###begin article-title 119
The molecular basis of vitamin D receptor and beta-catenin crossregulation.
###end article-title 119
###begin article-title 120
beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin.
###end article-title 120
###begin article-title 121
Vitamin D and skin cancer.
###end article-title 121
###begin article-title 122
Genetic defects of the 1,25-dihydroxyvitamin D3 receptor.
###end article-title 122
###begin article-title 123
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice.
###end article-title 123
###begin article-title 124
Vitamin D receptor is essential for normal keratinocyte stem cell function.
###end article-title 124
###begin article-title 125
Ligand-independent actions of the vitamin D receptor maintain hair follicle homeostasis.
###end article-title 125
###begin article-title 126
###xml 44 53 <span type="species:ncbi:10090">nude mice</span>
Vitamin D3 analogs stimulate hair growth in nude mice.
###end article-title 126
###begin article-title 127
Mechanism of action of superactive vitamin D analogs through regulated receptor degradation.
###end article-title 127
###begin article-title 128
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning.
###end article-title 128
###begin article-title 129
Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells.
###end article-title 129
###begin article-title 130
Stem cell depletion through epidermal deletion of Rac1.
###end article-title 130
###begin article-title 131
Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know?
###end article-title 131
###begin article-title 132
Homeodomain-mediated beta-catenin-dependent switching events dictate cell-lineage determination.
###end article-title 132
###begin article-title 133
Epidermal stem cells: an update.
###end article-title 133
###begin article-title 134
###xml 93 98 <span type="species:ncbi:9606">human</span>
The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer.
###end article-title 134
###begin article-title 135
E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations.
###end article-title 135
###begin article-title 136
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics.
###end article-title 136
###begin article-title 137
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Expression of DeltaNLef1 in mouse epidermis results in differentiation of hair follicles into squamous epidermal cysts and formation of skin tumours.
###end article-title 137
###begin article-title 138
Wnt proteins are lipid-modified and can act as stem cell growth factors.
###end article-title 138
###begin article-title 139
EMBOSS: the European Molecular Biology Open Software Suite.
###end article-title 139
###begin article-title 140
The UCSC Genome Browser Database.
###end article-title 140
###begin article-title 141
###xml 59 63 <span type="species:ncbi:10090">mice</span>
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects.
###end article-title 141
###begin article-title 142
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
Manipulation of stem cell proliferation and lineage commitment: visualisation of label-retaining cells in wholemounts of mouse epidermis.
###end article-title 142
###begin p 143
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 143
###begin p 144
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: HGP is the recipient of a European Union Marie Curie Fellowship. This work was supported by CR-UK.
###end p 144

